🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT04240366
Recruiting Not applicable

Additional Left Atrial Appendage Isolation During Balloon Ablation for Persistent or Long-standing Persistent Atrial Fibrillation

NCT04240366 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2019-12-17
Last updated
2024-08-29

Condition(s) studied

Persistent or Long-standing Persistent Atrial Fibrillation

Investigational drug(s) / intervention(s)

Control interventionExperimental intervention

Control intervention: patients treated with balloon-based ablation of AF by PVI

Experimental intervention: patients treated with balloon-based ablation of AF by PVI

Study summary

Additional left atrial appendage isolation during balloon ablation for persistent or long-standing persistent atrial fibrillation can reduce atrial fibrillation reoccurrence within 3-12 months compared to balloon-based pulmonary vein isolation only.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Persistent or long-standing persistent AF (i.e. continuous AF that was/is sustained \>7 days or \>12 months, respectively) 2. Age ≥18 and ≤80 years 3. Indication for AF ablation as per current guidelines Exclusion Criteria: 1. Missing informed consent 2. LAA diameter \>25mm 10mm distant from circumflex artery assessed by TEE 3. Paroxysmal atrial fibrillation 4. Long-standing persistent atrial fibrillation with a continuous AF duration of \>4 years 5. Previous pulmonary vein isolation or MAZE surgery 6. Previous led atrial appendage closure or surgical excision 7. Left atrial diameter \>60 mm at baseline 8. Left atrial thrombus at baseline

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
University Hospital Eppendorf, Hamburg, Germany Hamburg Free and Hanseatic City of Hamburg Recruiting
Asklepios Klinik Altona Hamburg Free and Hanseatic City of Hamburg Recruiting
Clinic for Rhythmologiy Luebeck, Schleswig-Holstein Germany Lübeck Schleswig-Holstein Recruiting

More University of Luebeck trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04240366 on ClinicalTrials.gov ↗ ← All trials in Germany